肌层浸润性膀胱癌新辅助免疫治疗中基于MRI的应答评估:三项前瞻性临床试验的放射科医师间变异性和诊断准确性分析
该研究分析三项前瞻性试验中115例肌层浸润性膀胱癌患者的mpMRI数据,评估新辅助免疫治疗前后多种定性及定量标准的放射科医师间一致性和对病理完全缓解的诊断准确性。结果显示视觉评估一致性高,半自动体积分析重复性好且准确,各方法对pCR均有较强预测性能。
要点
- 视觉评估在定性方法中放射科医师间一致性高(α=0.79)。
- 半自动体积分析重复性好且诊断准确(ICC=0.93,AUC=0.8–0.98)。
- 所有方法对pCR有较强预测性能,纵向体积变化兼顾重复性与准确性。
核心结论
- 半自动体积mpMRI评估是评估MIBC新辅助免疫治疗局部应答的可重复且准确的工具。
- 尽管仅关注原发肿瘤,这些发现支持其作为影像生物标志物和未来应答标准的基础。
- 其在临床决策中的作用仍需前瞻性验证。
研究设计与样本
- 分析三项前瞻性临床试验(NABUCCO、TURANDOT、PURE-01)共115例患者的数据。
- 患者在经尿道膀胱肿瘤电切术后及新辅助免疫治疗前、新辅助免疫治疗后及根治性膀胱切除术前接受mpMRI。
- 多位放射科医师使用定性(AJCC分期、nacVI-RADS、视觉应答、RECIST 1.1)和定量(直径、体积)标准评估放射学应答。
主要发现
- 视觉评估在定性方法中显示高放射科医师间一致性(α=0.79,95%CI:0.68–0.87)。
- 半自动体积分析在定量方面显示高重复性和准确性(ICC=0.93,95%CI:0.83–0.95,AUC=0.8–0.98)。
- 体积测量与ctDNA及肿瘤细胞密度呈中度相关。
- 所有方法对pCR均表现出较强预测性能,纵向体积变化在重复性与准确性之间表现出良好组合。
关键数值与推荐
- 定性视觉评估的放射科医师间一致性:Krippendorff's α=0.79(95%CI:0.68–0.87)。
- 半自动体积分析的重复性:ICC=0.93(95%CI:0.83–0.95)。
- 半自动体积分析对pCR的诊断准确性:AUC=0.8–0.98。
临床怎么用
- 半自动体积mpMRI评估可作为MIBC新辅助免疫治疗局部应答的可重复且准确的影像工具。
- 纵向体积变化兼顾重复性与准确性,可能有助于未来应答标准的制定。
- 目前尚不能用于临床决策,需前瞻性验证。
局限性
- 研究聚焦于原发肿瘤的应答评估。
- 半自动体积分析在临床决策中的作用尚需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: For patients with muscle-invasive bladder cancer (MIBC), accurate assessment of neoadjuvant therapy response may allow for bladder-sparing strategies, emphasizing the need for accurate, noninvasive response assessment. Multi-parametric magnetic resonance imaging (mpMRI) has emerged as a promising imaging modality, but its reproducibility and diagnostic performance following neoadjuvant immunotherapy remain underexplored. METHODS: We analyzed data from 115 patients across three prospective trials (NABUCCO, TURANDOT, and PURE-01). Patients underwent mpMRI after transurethral resection of bladder tumor and before neoadjuvant immunotherapy, and after neoadjuvant immunotherapy prior to radical cystectomy. Multiple radiologists assessed the radiological response using qualitative (AJCC Staging, nacVI-RADS, Visual Response, and RECIST 1.1) and quantitative (diameter, volumetric) criteria. Using Fleiss' kappa, Krippendorff's alpha, and intraclass-correlation coefficient (ICC), we assessed inter-radiologist variability. ROC-AUC (Receiver operator characteristic-area under the curve) assessed the diagnostic accuracy for pathological complete response (pCR) of the primary tumor, with correlations explored for circulating tumor (ctDNA) and tumor cell density. RESULTS: Visual assessment demonstrated high inter-radiologist agreement among qualitative methods (α = 0.79, 95% CI: [0.68-0.87]), while semi-automatic volumetric analysis showed high reproducibility and accuracy quantitatively (ICC = 0.93, 95% CI: [0.83-0.95], AUC = 0.8-0.98). Volumetric measurements showed moderate correlation with ctDNA and tumor cell density. All methods exhibited strong predictive performance for pCR, but longitudinal volume changes showed a good combination of reproducibility and accuracy. CONCLUSIONS: Semi-automatic volumetric mpMRI assessment is a reproducible and accurate tool for evaluating local response to neoadjuvant immunotherapy in MIBC. Despite focusing on the primary tumor, these findings support its potential as an imaging biomarker and foundation for future response criteria. However, confirming its role in clinical decision-making requires prospective validation.
引用
- Greidanus J, van Dijk-de Haan MC, Messina A, et al. MRI-based Response Assessment of Neoadjuvant Systemic Immunotherapy in Muscle-invasive Bladder Cancer: An Analysis of Inter-radiologist Variability and Diagnostic Accuracy in three Prospective Clinical Trials. Eur Urol Oncol. 2026. PMID: 42420156. doi:10.1016/j.euo.2026.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。